Lubabegron

Lubabegron is a pharmaceutical drug that is primarily used in the treatment of overactive bladder syndrome. It is classified as a beta-3 adrenergic agonist, a type of medication that works by relaxing the bladder muscles to prevent urgent, frequent or uncontrolled urination.

Mechanism of Action[edit | edit source]

Lubabegron works by stimulating the beta-3 adrenergic receptors found in the bladder. This stimulation causes the bladder muscles to relax, increasing the bladder's capacity to hold urine and reducing the urge to urinate frequently. This mechanism of action is similar to other beta-3 adrenergic agonists such as mirabegron.

Uses[edit | edit source]

The primary use of lubabegron is in the treatment of overactive bladder syndrome. This condition is characterized by an urgent need to urinate, frequent urination, and in some cases, incontinence. Lubabegron can help to alleviate these symptoms by relaxing the bladder muscles and increasing the bladder's capacity to hold urine.

Side Effects[edit | edit source]

Like all medications, lubabegron can cause side effects. Common side effects include nausea, dizziness, and headache. In rare cases, it can cause more serious side effects such as hypertension (high blood pressure), tachycardia (rapid heart rate), and urinary retention (difficulty fully emptying the bladder).

Contraindications[edit | edit source]

Lubabegron should not be used by individuals with severe hypertension, uncontrolled tachycardia, or severe renal impairment. It should also be used with caution in individuals with a history of urinary retention.